Skip to main content

Pakianathan Deepika

No open-market purchases or sales filed in the past year.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
–
0 filings
Net
–
Bought minus sold
Companies
0
With open-market trades

Trades

Every Form 4 that lists Pakianathan Deepika as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

MREO Mereo BioPharma Group plc

Director1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 23, 2024 (view filing)Aug 221 dayPakianathan DeepikaDirectorSSaleAmerican Depositary Shares representing Ordinary Shares−105.2K$4.43−$466.2K−100.0%0 after

KPTI Karyopharm Therapeutics Inc.

Director3 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jun 7, 2024 (view filing)Jun 5-72 daysPakianathan DeepikaDirectorSSale−818.0K$0.9601−$785.4K−100.0%0 after6 lots
Jun 4, 2024 (view filing)May 31-Jun 44 daysPakianathan DeepikaDirectorSSale−906.2K$0.9699−$878.9K−99.1%7.91K after6 lots
Jun 10, 2022 (view filing)Jun 8-102 daysPakianathan DeepikaDirectorSSale−538.8K$6.37−$3.43M−97.0%16.7K after6 lots

CALA Calithera Biosciences, Inc.

Director1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jan 31, 2023 (view filing)7:04 PM ETJan 274 daysPakianathan DeepikaDirectorSSale−121.3K$0.3858−$46.8K−100.0%0 after2 lots